| __timestamp | MorphoSys AG | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 63900978 | 116287000 |
| Thursday, January 1, 2015 | 106145897 | 136004000 |
| Friday, January 1, 2016 | 49646515 | 203017000 |
| Sunday, January 1, 2017 | 66757840 | 287023000 |
| Monday, January 1, 2018 | 74645876 | 393541000 |
| Tuesday, January 1, 2019 | 59670105 | 376095000 |
| Wednesday, January 1, 2020 | 318524319 | 467938000 |
| Friday, January 1, 2021 | 147400000 | 504714000 |
| Saturday, January 1, 2022 | 229647003 | 580017000 |
| Sunday, January 1, 2023 | 179923313 | 523742000 |
Unlocking the unknown
In the competitive landscape of the pharmaceutical industry, understanding financial performance is crucial. Over the past decade, from 2014 to 2023, MorphoSys AG and Supernus Pharmaceuticals, Inc. have showcased distinct trajectories in gross profit. Supernus Pharmaceuticals, Inc. has consistently outperformed MorphoSys AG, with an average gross profit nearly three times higher. Notably, in 2022, Supernus reached a peak gross profit, marking a 400% increase from 2014. Meanwhile, MorphoSys AG experienced a significant surge in 2020, with a gross profit increase of over 400% compared to 2016, yet it still trails behind Supernus. This data highlights the dynamic nature of the pharmaceutical sector, where strategic decisions and market conditions can lead to substantial financial shifts. As we look to the future, these trends offer valuable insights for investors and industry analysts alike.
Key Insights on Gross Profit: Amgen Inc. vs MorphoSys AG
Gilead Sciences, Inc. vs MorphoSys AG: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or Supernus Pharmaceuticals, Inc.
Incyte Corporation and MorphoSys AG: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Dr. Reddy's Laboratories Limited and MorphoSys AG
Gross Profit Trends Compared: Catalent, Inc. vs Supernus Pharmaceuticals, Inc.
Ascendis Pharma A/S vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Grifols, S.A. vs MorphoSys AG: A Gross Profit Performance Breakdown
Gross Profit Comparison: Amneal Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. Trends
HUTCHMED (China) Limited and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Ligand Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc. Trends
Who Generates Higher Gross Profit? Supernus Pharmaceuticals, Inc. or BioCryst Pharmaceuticals, Inc.